SCHEMBL6316628

SCHEMBL6316628

Cn1c(=O)c2nc(C=O)c(N3CCSCC3)nc2n(C)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.42
ALDH1A1 P00352 7/20 0.40
KDM4E B2RXH2 4/20 0.40
LMNA P02545 3/20 0.40
HTT P42858 3/20 0.40
HPGD P15428 2/20 0.40
JAK2 O60674 1/20 0.40
PAX8 Q06710 1/20 0.40
KMT2A Q03164 4/20 0.35
ADORA2A P29274 2/20 0.35
MAPT P10636 3/20 0.35
GAA P10253 2/20 0.34
GLA P06280 1/20 0.34
MEN1 O00255 2/20 0.33
THRB P10828 2/20 0.33
POLB P06746 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
BLM P54132 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
MAOB P27338 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6316327 0.87 ALDH1A1 (0.48) MAPK1ALDH1A1KDM4ELMNAHTT
SCHEMBL6321651 0.72 ALDH1A1 (0.47) MAPK1ALDH1A1KDM4ELMNAHTT
SCHEMBL6316016 0.69 ALDH1A1 (0.47) MAPK1ALDH1A1KDM4ELMNAHTT
SCHEMBL6401730 0.68 ALDH1A1 (0.54) MAPK1ALDH1A1KDM4ELMNAHTT
SCHEMBL6324023 0.68 ALDH1A1 (0.40) MAPK1ALDH1A1KDM4ELMNAHTT
SCHEMBL6313909 0.67 ALDH1A1 (0.53) MAPK1ALDH1A1KDM4ELMNAHTT
SCHEMBL6323060 0.67 ALDH1A1 (0.42) MAPK1ALDH1A1KDM4ELMNAHTT
SCHEMBL10524326 0.66 ALDH1A1 (0.63) ALDH1A1KDM4ELMNAHTTHPGD
SCHEMBL12355771 0.65 ALDH1A1 (0.61) ALDH1A1KDM4ELMNAHTTHPGD
SCHEMBL6313853 0.64 LMNA (0.46) MAPK1ALDH1A1KDM4ELMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6946465-B2 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2005-09-20 US claimed
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2003-12-25 US claimed
US-6946465-B2 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2005-09-20 US disclosed
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2003-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives TPMT, FKBP5, RRP15 MAPK1 3557/4885ALDH1A1 1744/4885KDM4E 1278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.